Advertisement

Ads Placeholder
Loading...

Graybug Vision, Inc.

GRAYNASDAQ
Healthcare
Biotechnology
$5.50
$-0.67(-10.80%)
U.S. Market opens in 26h 42m

Graybug Vision, Inc. (GRAY) Stock Overview

Explore Graybug Vision, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap121M
P/E Ratio-2.79
EPS (TTM)$-20.63
ROE-11.73%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

GRAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Graybug Vision, Inc. (GRAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.79 and a market capitalization of 121M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
1150.00%
3-Month Change
707.64%
6-Month Change
467.01%
Year-to-Date (YTD) Change
864.91%
1-Year Change
366.10%
3-Year Change
-66.67%
5-Year Change
-66.67%
All-Time (Max) Change
-66.67%

Contact Information

650 487 2800
203 Redwood Shores Parkway, Redwood City, CA, 94065

Company Facts

80 Employees
IPO DateSep 4, 2020
CountryUS

Frequently Asked Questions